INSTITUTIONAL & FAMILY ASSET MANAGEMENT, LLC - BIOCRYST PHARMACEUTICALS INC ownership

BIOCRYST PHARMACEUTICALS INC's ticker is BCRX and the CUSIP is 09058V103. A total of 208 filers reported holding BIOCRYST PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 0.67 and the average weighting 0.2%.

Quarter-by-quarter ownership
INSTITUTIONAL & FAMILY ASSET MANAGEMENT, LLC ownership history of BIOCRYST PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$2,818
+0.6%
3980.0%0.00%
Q2 2023$2,802
-15.6%
3980.0%0.00%
-100.0%
Q1 2023$3,319
-27.4%
3980.0%0.00%0.0%
Q4 2022$4,569
-8.6%
3980.0%0.00%0.0%
Q3 2022$5,000
+25.0%
398
-0.5%
0.00%0.0%
Q2 2022$4,000
-42.9%
4000.0%0.00%0.0%
Q1 2022$7,000
+16.7%
4000.0%0.00%0.0%
Q4 2021$6,0000.0%4000.0%0.00%0.0%
Q3 2021$6,0000.0%4000.0%0.00%0.0%
Q2 2021$6,000
+50.0%
4000.0%0.00%0.0%
Q1 2021$4,000
+33.3%
4000.0%0.00%0.0%
Q4 2020$3,000
+200.0%
4000.0%0.00%
Q3 2020$1,000
-50.0%
4000.0%0.00%
Q2 2020$2,000
+100.0%
4000.0%0.00%
Q1 2020$1,0000.0%4000.0%0.00%
Q4 2019$1,0000.0%4000.0%0.00%
Q3 2019$1,000
-50.0%
4000.0%0.00%
Q2 2019$2,000
-33.3%
4000.0%0.00%
-100.0%
Q1 2019$3,0000.0%4000.0%0.00%0.0%
Q4 2018$3,0000.0%4000.0%0.00%0.0%
Q3 2018$3,000
+50.0%
4000.0%0.00%
Q2 2018$2,0000.0%4000.0%0.00%
Q1 2018$2,0004000.00%
Other shareholders
BIOCRYST PHARMACEUTICALS INC shareholders Q4 2021
NameSharesValueWeighting ↓
Sarissa Capital Management LP 7,637,700$77,675,0007.44%
Burrage Capital Management LLC 864,916$8,796,0007.13%
ORACLE INVESTMENT MANAGEMENT INC 2,367,670$24,079,0003.61%
HealthCor Management, L.P. 4,886,440$49,695,0001.76%
Ghost Tree Capital, LLC 500,000$5,085,0001.20%
Integral Health Asset Management, LLC 400,000$4,068,0001.16%
Lisanti Capital Growth, LLC 472,520$4,806,0000.62%
Parkman Healthcare Partners LLC 244,680$2,488,0000.58%
Baker Brothers Advisors 12,710,818$129,269,0000.56%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 2,605,380$26,497,0000.56%
View complete list of BIOCRYST PHARMACEUTICALS INC shareholders